Molecular and serological diagnosis of Borrellia burgdorferi infection among patients with diagnosed erythema migrans

• Autorzy: Kondrusik M. , Grygorczuk S. , Skotarczak B. , Wodecka B. , Rymaszewska A. , Pancewicz S. , Zajkowska J. , Swierzbinska R. , Hermanowska-Szpakowicz T.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to assess the frequency of Borrelia burgdorferi DNA detection in the blood and urine of patients diagnosed with erythema migrans, and compare the results of PCR-based methods with ELISA methodology. The latter was used to detect serum antibodies against Borrelia burgdorferi of the IgM and IgG classes, before and after antibiotic therapy. The study included 86 patients hospitalized in the Department of Infectious Diseases and Neuroinfections in the Medical Academy in Białystok, diagnosed with the erythema migrans phase of Lyme borreliosis. Examinations were carried out twice: the fi rst at the moment of diagnosis (Trial 1), the second after 4 weeks of antibiotic therapy. The study showed that antibiotic therapy in the early phase of borreliosis does not decrease the sensitivity of PCR and that after 4 weeks of therapy (Trial 2), spirochete DNA is still detectable in most patients (45/86). There was no correlation between detectability of spirochete DNA and the presence of antibodies against B. burgdorferi s.l. (assessed by ELISA) during the course of erythema migrans. The largest percentage of positive results in the detection of B. burgdorferi s.l. DNA was observed in patients who simultaneously possessed IgM and IgG antibodies against B. burgdorferi, while the lowest percentage of PCR positive results was among patients with only IgM antibodies.

Słowa kluczowe

EN

human disease; erythema migrans phase; patient; diagnosis; ELISA test; polymerase chain reaction; serological diagnosis; Borrelia burgdorferi; borreliosis

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2007
• Tom: 14
• Numer: 2
• Opis fizyczny: p.209-213,ref.

Twórcy

autor

Kondrusik M.

• Medical University, Zurawia 14, 15-540 Bialystok, Poland

autor

Grygorczuk S.

autor

Skotarczak B.

autor

Wodecka B.

autor

Rymaszewska A.

autor

Pancewicz S.

autor

Zajkowska J.

autor

Swierzbinska R.

autor

Hermanowska-Szpakowicz T.

Bibliografia

• Bunikis J, Barbour AG: Laboratory testing for suspected Lyme disease. Med Clin N Am 2002, 86, 311-339.
• Goodman JL, Bradley JF, Ross AE, Goellner P, Lagus A, Vitale B, Berger BW, Luger S, Johnson RC: Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blionded study using the polymerase chain reaction. Am J Med 1995, 99, 6-12.
• Lange R, Seyyedi S: Evidence of a Lyme borreliosis infection from the viewpoint of laboratory medicine. Int J Med Microbiol 2002, 291 (Suppl 33), 120-124.
• Lebech AM, Hansen K, Brandrup F, Clemmensen C, Halkier-Sorensen L: Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with Erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000, 5, 139-150.
• Lebech AM: Polymerase chain reaction in diagnosis of Borrelia burgdorferi infection and studies on taxonomic classification. APMIS 2002, 105, 1-40.
• Marconi RT, Garon CF: Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 1992, 11, 2830-2834.
• Molloy PJ, Persing DH, Berardi VP: False-positive results of PCR testing for Lyme diseases. Clin Infect Dis 2001, 33, 412-413.
• Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelmann RB, Cavaliere LF, Wormser GP: Laboratory techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001, 15(33), 2023-2027.
• Oksi J, Marttila H, Soini H, Ano H, Uksila J, Viljanen MK: Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 2001, 109(9), 581-588.
• Pleyer U, Priem S, Bergmann L, Burmester G, Hartmann C, Krause A: Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br J Ophtalmol 2001, 85(5), 552-555.
• Priem S, Rittig MG, Kamradt T, Burmester GR, Krause A: An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme disease. J Clin Microbiol 1997, 35, 685-690.
• Schwartz I, Wormser GP, Schwartz JJ, Cooper D, Weisensee P, Zimmermann F, Goldberg NN, Bitter S, Campbell GL: Diagnosis of early Lyme disease by polymerase chain reaction amplifi cation and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992, 30, 3082-3088.
• Steere AC: Lyme disease. N Engl J Med 2001, 345, 115-125. Tylewska-Wierzbanowska S, Chmielewski T: Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods. Wien Klin Wochenschr 2002, 114(13-14), 601-605.
• Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelmann RB, Pavia C: Comparison of yield of blood cultures using serum or plasma from patients with early Lyme disease. J Clin Microbiol 2000, 38, 1648-1650.
• Zore A, Ruzic-Sabljis E, Maraspin V, Cimpermann J, Lotric-Furlan S, Pikolj A, Jurca T, Logar H, Strle F: Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin Wochenschr 2002, 114(13-14), 606-609.